Search

Search Results

• PO:02:022 | Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies Fabian Proft¹, Désirée Van Der Heijde², Sergio Schwartzman^3|4|5, Joerg Ermann⁶, Alexander Marten⁷, Ute Massow⁷, George Stojan⁸, Vanessa Taieb⁹, Diana Voiniciuc¹⁰, Astrid Van Tubergen¹¹, Victoria Navarro-Compán¹², Simone Angioni¹³, Xenofon Baraliakos¹⁴ | ¹Charité-Universitätsmedizin Berlin; Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; ²Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; ³Weill Cornell Medical Center New York, USA; ⁴New York Presbyterian Hospital New York, USA; ⁵Hospital for Special Surgery New York, USA; ⁶Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School Boston, USA; ⁷UCB Monheim am Rhein Germany; ⁸UCB Atlanta, USA; ⁹UCB Colombes, France; ¹⁰UCB Slough, United Kingdom; ¹¹Department of Medicine, Division of Rheumatology, Maastricht University Medical Center Maastricht, The Netherlands; ¹²Department of Rheumatology, La Paz University Hospital, IdiPaz Madrid, Spain; ¹³UCB Milan, Italy; ¹⁴Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2285

  13

• PO:01:011 | Achievement of Remission Defined by Absence of Objective Signs of Inflammation Versus ASDAS ID in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Studies Lianne S Gensler¹, Helena Marzo-Ortega², Vanessa Taieb³, Diana Voiniciuc⁴, Alexander Marten⁵, George Stojan⁶, Mindy Kim⁶, Paolo Marsico⁷, Martin Rudwaleit⁸ | ¹Department of Medicine/Rheumatology, University of California San Francisco, USA; ²NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom; ³UCB Colombes, France; ⁴UCB Slough, United Kingdom; ⁵UCB Monheim am Rhein Germany; ⁶UCB Atlanta, USA; ⁷UCB Milan, Italy; ⁸University of Bielefeld, Klinikum Bielefeld Bielefeld Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2282

  17